Cochlear Bull Thinks Volumes Can Recover With Time -- Market Talk

Dow Jones
04/22

0633 GMT - Cochlear's bull at Jefferies slashes their target price on the hearing-implant maker's guidance downgrade while thinking market volumes can recover over the longer term. Analyst David Stanton tells clients in a note that the investment bank's channel checks suggest that health insurers in developed and developing markets are under pressure, which leads to delays in demand for implants. Stanton points out that insurers in developed markets are increasing deductibles, while many patients see implantation as a semi-elective procedure that can be delayed. Jefferies cuts its target price 52% to A$137.00 and keeps a buy rating on the stock, which closed 41% lower at A$99.58. (stuart.condie@wsj.com)

 

(END) Dow Jones Newswires

April 22, 2026 02:33 ET (06:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10